Registration number:
Unaudited Abbreviated Accounts
for the Year Ended
Molecular Discovery Limited
Contents
|
|||
|
Molecular Discovery Limited
(Registration number: 1866803)
Abbreviated Balance Sheet at 31 March 2015
Note |
2015
|
(As restated)
|
|||||||
Fixed assets |
|||||||||
Tangible fixed assets |
|
|
|||||||
Current assets |
|||||||||
Debtors |
|
|
|||||||
Investments |
|
- |
|||||||
Cash at bank and in hand |
|
|
|||||||
|
|
||||||||
Creditors: Amounts falling due within one year |
( |
( |
|||||||
Net current assets |
|
|
|||||||
Net assets |
|
|
|||||||
Capital and reserves |
|||||||||
Called up share capital |
|
|
|||||||
Profit and loss account |
|
|
|||||||
Shareholders' funds |
|
|
Approved by the director on
F Cruciani
Director
1
Molecular Discovery Limited
Notes to the Abbreviated Accounts for the Year Ended 31 March 2015
......... continued
Accounting policies |
Basis of preparation
Turnover
Fixed assets
All fixed assets are initially recorded at cost.
Depreciation
Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful economic life of that asset as follows:
Asset class |
Depreciation method and rate |
Fixtures & Fittings |
|
Leasehold improvements |
|
Current asset investments
Deferred tax
Molecular Discovery Limited
Notes to the Abbreviated Accounts for the Year Ended 31 March 2015
......... continued
Foreign currency
Hire purchase and leasing
Financial instruments
Fixed assets |
Tangible assets
|
Total
|
|||||
Cost |
||||||
At 1 April 2014 |
629,123 |
629,123 |
||||
Additions |
225,543 |
225,543 |
||||
At 31 March 2015 |
854,666 |
854,666 |
||||
Depreciation |
||||||
At 1 April 2014 |
448,158 |
448,158 |
||||
Charge for the year |
90,748 |
90,748 |
||||
At 31 March 2015 |
538,906 |
538,906 |
||||
Net book value |
||||||
At 31 March 2015 |
|
|
||||
At 31 March 2014 |
|
|
Debtors |
Debtors includes £32,100 (2014 - £37,500) receivable after more than one year.
Molecular Discovery Limited
Notes to the Abbreviated Accounts for the Year Ended 31 March 2015
......... continued
Share capital |
Allotted, called up and fully paid shares
2015 |
2014 |
|||||||||||
No. |
£ |
No. |
£ |
|||||||||
|
|
|
|
|
||||||||
Prior period adjustments |
Control |